| Name | Title | Contact Details |
|---|
Trevi Therapeutics, Inc. is a late-stage clinical development company developing Nalbuphine® ER for chronic pruritus (itch). Pruritus develops in various dermatologic, metabolic, hematologic, and neuropathic conditions. The Company is pursuing two conditions for clinical development: uremic pruritus and prurigo nodularis. Uremic pruritus is a persistent and debilitating itch in patients on dialysis that has been associated with significant impairment in quality of life and increased mortality. Prurigo nodularis is an intensely pruritic dermatologic condition characterized by unsightly and itchy skin papules and nodules. There are no approved therapies in the United States or Europe for either condition.
Insertec is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
200 Pharmacy & Home Medical Supplies is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Marena offers medical grade compression garments including post op garments, compression shapewear, compression activewear, and more.
At iA, we partner with our customers to transform pharmacy by deepening the patient-pharmacist relationship, enhancing patient safety and increasing operational efficiency.